Log In
Print
BCIQ
Print
Print this Print this
 

ABT-267

  Manage Alerts
Collapse Summary General Information
Company AbbVie Inc.
DescriptionHCV NS5A protein inhibitor
Molecular Target HCV NS5A protein
Mechanism of ActionHCV non-structural protein 5A inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat HCV genotype 1 infection; Treat HCV genotype 1b infection; Treat HCV genotype 2 infection; Treat HCV infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today